| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,688 |
Update - Notification of buy-back - ORA
|
19 Nov 2025 8:33AM |
$2.210 |
$2.170 |
fallen by
1.81%
|
|
| WAM Research Limited (WAX) ORDINARY FULLY PAID |
Financials |
$255 |
Annual General Meeting Chairman's Address
|
19 Nov 2025 8:33AM |
$1.225 |
$1.225 |
fallen by
0%
|
|
| WAM Global Limited (WGB) ORDINARY FULLY PAID |
Financials |
$882 |
Annual General Meeting Chairman's Address
|
19 Nov 2025 8:33AM |
$2.440 |
$2.460 |
risen by
0.82%
|
|
| Sportshero Limited (SHO) ORDINARY FULLY PAID |
Communication Services |
$33 |
Mobile Casual Gaming Product goes live in Indonesia
|
19 Nov 2025 8:33AM |
$0.038 |
$0.040 |
risen by
5.26%
|
|
SHO - Price-sensitive ASX Announcement
Full Release
Key Points
- HeroPlay launched in Indonesia via Indosat Ooredoo Hutchison.
- Access to over 600 HTML5 mobile games.
- No app download required; games are played via internet browsers.
- Direct Carrier Billing allows easy subscription.
- Revenue split: 65% SportsHero, 35% Indosat.
- Gross margin expected between 35% and 85%.
- Strategic expansion into Southeast Asia.
- Indosat supports marketing through its large user base.
- HeroPlay includes games across various genres like puzzles, sports, and strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$220 |
2025 AGM Presentation and Upgrade to FY26 Revenue Guidance
|
19 Nov 2025 8:33AM |
$1.720 |
$1.550 |
fallen by
9.88%
|
|
ACE - Price-sensitive ASX Announcement
Full Release
Key Points
- Acusensus upgrades FY26 revenue guidance to $83m - $87m.
- Revenue growth driven by new contracts and expansions.
- New Zealand speed enforcement contract mobilization successful.
- Connecticut Automated Work Zone Speed Control contract valued at approximately $34m.
- Expansion of Western Australia and Queensland contracts.
- Focus on AI-enabled road safety solutions to combat distracted driving.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,614 |
Notification of cessation of securities - MFG
|
19 Nov 2025 8:33AM |
$9.210 |
$9.500 |
risen by
3.15%
|
|
| Osmond Resources Limited (OSM) ORDINARY FULLY PAID |
Materials |
$95 |
First hole confirms world-class Spanish - EU discovery
|
19 Nov 2025 8:33AM |
$1.000 |
$0.750 |
fallen by
25%
|
|
OSM - Price-sensitive ASX Announcement
Full Release
Key Points
- First drill hole (AV-01) confirms world-class grades of Ti, Zr, and REE.
- Assay results include 1.5m at 15.92% TiO2, 5.67% ZrO2, 1.15% TREO.
- The Orión EU Critical Minerals Project is located in Spain.
- The primary mineral layer contains rutile, ilmenite, zircon, and monazite.
- Continuous drilling and analysis are underway to explore further potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,614 |
Update - Notification of buy-back - MFG
|
19 Nov 2025 8:33AM |
$9.210 |
$9.500 |
risen by
3.15%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,348 |
Net Tangible Asset Backing
|
19 Nov 2025 8:32AM |
$3.470 |
$3.710 |
risen by
6.92%
|
|
| BCAL Diagnostics Limited (BDX) ORDINARY FULLY PAID |
Health Care |
$37 |
BCAL Early Cancer Detection Tests Update
|
19 Nov 2025 8:32AM |
$0.084 |
$0.100 |
risen by
19.05%
|
|
BDX - Price-sensitive ASX Announcement
Full Release
Key Points
- BCAL is on track to launch Avantect® Pancreatic and Ovarian cancer tests in January 2026.
- ClearNote secured UK approval for Avantect® tests.
- BREASTESTplusâ„¢ expands to women with breast density C.
- Telehealth service to launch in Q1 2026 for early-detection consultations.
- Avantect® Pancreatic test targets new onset type 2 diabetes patients for pancreatic cancer surveillance.
- BCAL's BREASTESTplusâ„¢ now covers about 50% of women screened for breast disease.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$3,867 |
Update - Notification of buy-back - ZIP
|
19 Nov 2025 8:32AM |
$2.940 |
$3.030 |
risen by
3.06%
|
|
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$220 |
2025 AGM Chair Address
|
19 Nov 2025 8:32AM |
$1.720 |
$1.550 |
fallen by
9.88%
|
|
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$92 |
Bell Potter Healthcare conference presentation
|
19 Nov 2025 8:32AM |
$0.450 |
$0.505 |
risen by
12.22%
|
|
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$133 |
2025 AGM Chair Address and Presentation
|
19 Nov 2025 8:32AM |
$0.330 |
$0.310 |
fallen by
6.06%
|
|
| FSA Group Limited (FSA) ORDINARY FULLY PAID |
Financials |
$155 |
Update - Notification of buy-back - FSA
|
19 Nov 2025 8:32AM |
$1.185 |
$1.280 |
risen by
8.02%
|
|
| Diversified United Investment Limited (DUI) ORDINARY FULLY PAID |
Financials |
$1,140 |
Update - Notification of buy-back - DUI
|
19 Nov 2025 8:32AM |
$5.220 |
$5.310 |
risen by
1.72%
|
|
| Decidr AI Industries Ltd (DAI) ORDINARY FULLY PAID |
Consumer Staple |
$176 |
Decidr To Enter US Market with Acquisition of Sugarwork, Inc
|
19 Nov 2025 8:32AM |
$0.680 |
$0.560 |
fallen by
17.65%
|
|
DAI - Price-sensitive ASX Announcement
Full Release
Key Points
- Decidr AI Industries Ltd to acquire 100% of Sugarwork, Inc.
- Sugarwork specializes in AI knowledge transfer and workflow automation.
- The acquisition facilitates Decidr's entry into the US market.
- Transaction structured as a scrip-for-scrip equity swap.
- Sugarwork's customer base spans finance, healthcare, and industrial sectors.
- The acquisition supports Decidr's mission to expand its Agentic AI platform.
- Integration aims to enhance AI workflow monetization and adoption.
- Transaction completion subject to customary closing conditions.
- Investor webinar scheduled to discuss the acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QuickFee Limited (QFE) ORDINARY FULLY PAID |
Financials |
$29 |
Application for quotation of securities - QFE
|
19 Nov 2025 8:32AM |
$0.125 |
$0.077 |
fallen by
38.40%
|
|
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$86,992 |
Update - Notification of buy-back - CSL
|
19 Nov 2025 8:32AM |
$180.080 |
$179.310 |
fallen by
0.43%
|
|
| Medibank Private Limited (MPL) ORDINARY FULLY PAID |
Financials |
$13,137 |
2025 AGM Chair and CEO Address
|
19 Nov 2025 8:31AM |
$4.810 |
$4.770 |
fallen by
0.83%
|
|
| OMG Group Limited (OMG) ORDINARY FULLY PAID |
Consumer Staple |
$9 |
Distribution Agreement with Japanese matcha manufacturer
|
19 Nov 2025 8:31AM |
$0.011 |
$0.010 |
fallen by
9.09%
|
|
OMG - Price-sensitive ASX Announcement
Full Release
Key Points
- OMG Group Limited has entered into a five-year exclusive distribution agreement with SANDAI, a premium matcha manufacturer from Nagasaki, Japan.
- The agreement involves the supply of 350,000kg of ceremonial-grade matcha per year.
- OMG Group will use a multi-channel strategy to distribute SANDAI matcha in Australia and internationally.
- The matcha market is valued at US$4.3Bn in 2023, expected to grow to US$7.43Bn by 2030.
- OMG Group plans to launch new matcha-infused products and act as a wholesale distributor.
- The company aims to leverage existing networks in grocery chains, cafes, and ecommerce channels.
- OMG's CEO emphasizes the strategic significance of this agreement for high-margin sales growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$212 |
Update - Notification of buy-back - CAA
|
19 Nov 2025 8:31AM |
$11.490 |
$12.990 |
risen by
13.05%
|
|
| Warriedar Resources Limited (WA8) ORDINARY FULLY PAID |
Materials |
$333 |
Ceasing to be a substantial holder
|
19 Nov 2025 8:31AM |
$0.265 |
$0.265 |
fallen by
0%
|
|
| Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,123 |
Update - Notification of buy-back - LFSPA
|
19 Nov 2025 8:30AM |
$1.130 |
$1.080 |
fallen by
4.42%
|
|
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$109 |
Cyclopharm Bell Potter Healthcare Conference Presentation
|
19 Nov 2025 8:30AM |
$0.665 |
$0.980 |
risen by
47.37%
|
|
CYC - Price-sensitive ASX Announcement
Full Release
Key Points
- Cyclopharm Limited aims for 250-300 Technegas installations in the U.S. by second half CY2026.
- Technegas offers high diagnostic accuracy and low radiation exposure.
- Expansion into chronic respiratory diseases market, such as COPD and asthma.
- Significant presence in 66 countries with plans to leverage AI and analytical software.
- U.S. sales force expansion and strong pipeline of revenue-generating sites.
- Focus on recurring revenue through consumable sales and annual access fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.